PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, United States.\', \'Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, United States. Electronic address: Narayan.Nair@fda.hhs.gov.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00524-710.1016/j.vaccine.2021.04.054
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34006408
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all